Web Analytics

3 Latest Announced Rounds

  • $2,200,000
    Pre-Seed

    4 Investors

    Software Development
    Jan 22nd, 2025
  • $347,401
    Seed

    1 Investors

    Biotechnology Research
    Jan 22nd, 2025
  • $12,000,000
    Series A

    3 Investors

    Software Development
    Jan 22nd, 2025
$1,269.37M Raised in 45 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Enthea

start up
United States - Boston
  • 19/12/2022
  • Seed
  • $2,000,000

Psychedelic Healthcare as a Workplace Benefit.
Creating benefit plans for progressive, compassionate employers.
We are on a mission to expedite safe, affordable access to psychedelic-assisted therapy for all who can benefit.
Supporting healing from within.


Related People

Sherry R.Founder

Sherry R. Canada - Toronto, Ontario

I have helped dozens of startups, non-profit organizations, academic/research institutions, and small businesses raise funds, operate according to their mission and values, and implement processes that enhance their efficiency.

I believe in living and working in alignment with purpose and I am currently focused on expanding access to psychedelic-assisted therapy to alleviate human suffering.

Before this, I consulted with the United Nations and World Bank for 10 years, implementing cash transfer programs at the national level in over 35 countries.

I have a Master’s Degree in Public Policy and Management from the London School of Economics and a Bachelor’s Degree in Neuroscience and International Development from McGill University. I also completed the Certificate in Psychedelic Therapies and Research from CIIS in 2021.

In addition to being Enthea's CEO, I am the Executive Director of the Boston Psychedelic Research Group, HR Consultant for Sensorium Therapeutics, and Strategic Advisor for CIIS.